{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:11:45Z","timestamp":1792987905627,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.kint.2015.12.004","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T05:21:41Z","timestamp":1453440101000},"page":"289-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Changing bone patterns with progression of chronic kidney disease"],"prefix":"10.1016","volume":"89","author":[{"given":"Tilman B.","family":"Dr\u00fceke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2015.12.004_bib1","first-page":"34","article-title":"Osteitis fibrosa cystica","volume":"8","author":"Davies","year":"1915","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.kint.2015.12.004_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI100262","article-title":"A\u00a0case of osteitis fibrosa cystica (osteomalacia?) with evidence of hyperactivity of the para-thyroid bodies. Metabolic Study Ii","volume":"8","author":"Bauer","year":"1930","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.12.004_bib3","first-page":"377","article-title":"Renal osteitis fibrosa cystica","volume":"60","author":"Albright","year":"1937","journal-title":"Bull\u00a0Johns Hopkins Hosp"},{"key":"10.1016\/j.kint.2015.12.004_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.95.2467.388","article-title":"Treatment of renal osteodystrophy with dihydrotachysterol (A.T.10) and iron","volume":"95","author":"Liu","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.kint.2015.12.004_bib5","first-page":"771","article-title":"Renal osteodystrophy","volume":"133","author":"Norman","year":"1947","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.kint.2015.12.004_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM197205182862009","article-title":"On the pathogenesis of the uremic state. An exposition of the \u201ctrade-off hypothesis.\u201d","volume":"286","author":"Bricker","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.12.004_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.12.004_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(78)90191-5","article-title":"Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminium","volume":"1","author":"Ward","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2015.12.004_bib9","first-page":"295","article-title":"Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies","volume":"19","author":"Touam","year":"1983","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome. Possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.12.004_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM198404263101704","article-title":"Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis","volume":"310","author":"Andreoli","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.12.004_bib12","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.64.s87.19.x","article-title":"An update on vitamin D as related to nephrology practice: 2003","author":"Coburn","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2015.12.004_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1525-139X.2005.18404.x","article-title":"Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy","volume":"18","author":"Hernandez","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2015.12.004_bib14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2015.12.004_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","article-title":"Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?","volume":"34","author":"Evenepoel","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.004_bib18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","article-title":"Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications","volume":"30","author":"Morena","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/ndt\/gfv048","article-title":"Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease","volume":"30","author":"Gajjala","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-319-07320-0_14","article-title":"The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease","volume":"824","author":"Gugliucci","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.kint.2015.12.004_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MNH.0000000000000062","article-title":"Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?","volume":"23","author":"Mallipattu","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2015.12.004_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.ajkd.2004.09.011","article-title":"Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients","volume":"45","author":"Descamps-Latscha","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.004_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/1354750X.2012.749302","article-title":"Clinical and research markers\u00a0of oxidative stress in chronic kidney disease","volume":"18","author":"Tucker","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.kint.2015.12.004_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.ajkd.2014.04.034","article-title":"Protein carbamylation in kidney disease: pathogenesis and clinical implications","volume":"64","author":"Kalim","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.004_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ki.2015.166","article-title":"Protein carbamylation and cardiovascular disease","volume":"88","author":"Verbrugge","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5935\/0101-2800.20140033","article-title":"The quest for a better understanding of chronic kidney disease complications: an update on uremic toxins","volume":"36","author":"Barreto","year":"2014","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.kint.2015.12.004_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib28","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib30","first-page":"70","article-title":"Vitamin D3 metabolites in chronic renal failure and after renal transplantation","volume":"3","author":"Lucas","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ndt\/gfu291","article-title":"The demonstration of alphaKlotho deficiency in human chronic kidney disease with a novel synthetic antibody","volume":"30","author":"Barker","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000346778","article-title":"Klotho and chronic kidney disease","volume":"180","author":"Hu","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000380970","article-title":"Klotho\/FGF23 axis in CKD","volume":"185","author":"Tsuchiya","year":"2015","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib35","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.12.004_bib36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2015.12.004_bib37","doi-asserted-by":"crossref","first-page":"p23","DOI":"10.1159\/000093277","article-title":"FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation","volume":"104","author":"Pande","year":"2006","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.kint.2015.12.004_bib38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.kint.2015.12.004_bib40","doi-asserted-by":"crossref","first-page":"e40242","DOI":"10.1371\/journal.pone.0040242","article-title":"Measuring parathyroid hormone (PTH) in patients with oxidative stress: do we need a fourth generation parathyroid hormone assay?","volume":"7","author":"Hocher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.12.004_bib41","doi-asserted-by":"crossref","unstructured":"Stinghen AE, Massy ZA, Vlassara H, et\u00a0al. Uremic toxicity of advanced glycation end products in CKD [e-pub ahead of print]. J Am Soc Nephrol. http:\/\/dx.doi.org\/10.1681\/ASN.2014101047.","DOI":"10.1681\/ASN.2014101047"},{"key":"10.1016\/j.kint.2015.12.004_bib42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ki.2013.254","article-title":"Recent advances in the noninvasive diagnosis of renal osteodystrophy","volume":"84","author":"Moorthi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semnephrol.2009.01.006","article-title":"A\u00a0structural approach to skeletal fragility in chronic kidney disease","volume":"29","author":"Leonard","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib44","first-page":"332","article-title":"Osteomalacia in patients with chronic renal failure before dialysis or transplantation","volume":"52","author":"Mora Palma","year":"1983","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.kint.2015.12.004_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib46","series-title":"Bony Complications of Renal Disease","author":"Stanbury","year":"1967"},{"key":"10.1016\/j.kint.2015.12.004_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.0954-6820.1988.tb16754.x","article-title":"Renal osteodystrophy in predialysis patients without stainable bone aluminum. A cross-sectional bone-histomorphometric study","volume":"224","author":"Dahl","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.kint.2015.12.004_bib49","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib50","first-page":"135","article-title":"Adynamic bone disease-bone and beyond","volume":"1","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/j.kint.2015.12.004_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2014.07.037","article-title":"Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD)","volume":"68","author":"Ng","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.kint.2015.12.004_bib52","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.1993.350","article-title":"Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease","volume":"44","author":"Hutchison","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ndt\/9.5.517","article-title":"Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis","volume":"9","author":"Hernandez","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/8756-3282(92)90354-Y","article-title":"Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?","volume":"13","author":"Cohen-Solal","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.kint.2015.12.004_bib55","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jcem-69-6-1166","article-title":"Relationships between histomorphometric features of bone formation and bone cell characteristics in\u00a0vitro in renal osteodystrophy","volume":"69","author":"Marie","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2015.12.004_bib56","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/oxfordjournals.ndt.a027089","article-title":"PTH\/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats","volume":"11","author":"Urena","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.79","article-title":"The renal PTH\/PTHrP receptor is down-regulated in rats with chronic renal failure","volume":"45","author":"Urena","year":"1994","journal-title":"Kidney Int"},{"issue":"suppl 2","key":"10.1016\/j.kint.2015.12.004_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/17.suppl_2.13","article-title":"Intestinal absorption of aluminium in renal failure","volume":"17","author":"Drueke","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib59","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/ph7100990","article-title":"Ferric citrate hydrate as a phosphate binder and risk of aluminum toxicity","volume":"7","author":"Gupta","year":"2014","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.kint.2015.12.004_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/cs0920063","article-title":"Effects of silicon, citrate and the fasting state on the intestinal absorption of aluminium in rats","volume":"92","author":"Drueke","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.kint.2015.12.004_bib61","first-page":"289","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.kint.2015.12.004_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1359\/jbmr.090735","article-title":"Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment","volume":"25","author":"Tomiyama","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.12.004_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02013242","article-title":"Tetracycline double-labeling of iliac trabecular bone in 41 normal adults","volume":"26","author":"Melsen","year":"1978","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.kint.2015.12.004_bib64","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","article-title":"Indoxyl sulphate inhibits osteoclast\u00a0differentiation and function","volume":"27","author":"Mozar","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib65","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib67","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1681\/ASN.V34947","article-title":"Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity","volume":"3","author":"Hsu","year":"1992","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.12.004_bib69","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"Evenepoel","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib71","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.12.004_bib72","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1210\/me.2012-1062","article-title":"Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice","volume":"26","author":"Martin","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.kint.2015.12.004_bib73","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.kint.2015.12.004_bib74","doi-asserted-by":"crossref","first-page":"e0120856","DOI":"10.1371\/journal.pone.0120856","article-title":"Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients","volume":"10","author":"Pereira","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.12.004_bib75","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ki.2013.443","article-title":"Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD","volume":"85","author":"Jorgetti","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib76","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1093\/ndt\/gfq316","article-title":"Racial differences in postprandial mineral ion handling in health and in chronic kidney disease","volume":"25","author":"Gutierrez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib77","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1681\/ASN.V112330","article-title":"Race is a major determinant of secondary hyperparathyroidism in uremic patients","volume":"11","author":"Gupta","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib78","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1523-1755.2003.00129.x","article-title":"Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease","volume":"64","author":"Sawaya","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib79","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.12.004_bib80","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1306357","article-title":"Vitamin D-binding protein and vitamin D status of black Americans and white Americans","volume":"369","author":"Powe","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.12.004_bib81","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib82","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/jcem.84.2.5485","article-title":"Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction","volume":"84","author":"Lafage-Proust","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"suppl 3","key":"10.1016\/j.kint.2015.12.004_bib83","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2215\/CJN.02500607","article-title":"Effects of treatment of renal osteodystrophy on bone histology","volume":"3","author":"Malluche","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib84","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib85","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jsbmb.2006.12.089","article-title":"Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?","volume":"103","author":"Brown","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.kint.2015.12.004_bib86","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1525-139X.2005.18407.x","article-title":"The role of vitamin D in vascular calcification in chronic kidney disease","volume":"18","author":"Wolisi","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2015.12.004_bib88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2174\/138161211795428786","article-title":"The role of vitamin D in dyslipidemia and cardiovascular disease","volume":"17","author":"Zittermann","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.kint.2015.12.004_bib89","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib90","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","article-title":"A\u00a0multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients","author":"D'Haese","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2015.12.004_bib91","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","article-title":"Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up","volume":"21","author":"Spasovski","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib92","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MNH.0b013e32832c4df0","article-title":"Adynamic bone disease: clinical and therapeutic implications","volume":"18","author":"Frazao","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2015.12.004_bib94","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1542-4758.2006.00125.x","article-title":"Review of dialysate calcium concentration in hemodialysis","volume":"10","author":"Toussaint","year":"2006","journal-title":"Hemodial Int"},{"key":"10.1016\/j.kint.2015.12.004_bib95","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib96","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bone.2007.06.014","article-title":"Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium","volume":"41","author":"Spasovski","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.kint.2015.12.004_bib97","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3747\/pdi.2013.00177","article-title":"Calcium balance and negative impact of calcium load in peritoneal dialysis patients","volume":"34","author":"Wang","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2015.12.004_bib98","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.372","article-title":"Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease","volume":"87","author":"de Oliveira","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib99","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","article-title":"Incidence and risk factors for hip fractures in dialysis patients","volume":"25","author":"Maravic","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2015.12.004_bib100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00774-012-0411-z","article-title":"Increased risk of hip fracture among Japanese hemodialysis patients","volume":"31","author":"Wakasugi","year":"2013","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2015.12.004_bib101","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib102","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1744-9987.12074","article-title":"Regional variation in hip fracture incidence among Japanese hemodialysis patients","volume":"18","author":"Wakasugi","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.kint.2015.12.004_bib103","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000369039","article-title":"Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis","volume":"40","author":"Mathew","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib104","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2215\/CJN.10901012","article-title":"Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States","volume":"8","author":"Nair","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ndt\/gft352","article-title":"Increased bone fractures among elderly United States hemodialysis patients","volume":"29","author":"Wagner","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib106","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib107","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","article-title":"In elderly men and women treated for osteoporosis a low creatinine clearance of\u00a0<65 ml\/min is a risk factor for falls and fractures","volume":"16","author":"Dukas","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2015.12.004_bib108","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2015.12.004_bib109","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2215\/CJN.09130912","article-title":"Estimated GFR and fracture risk: a population-based study","volume":"8","author":"Elliott","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib111","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","article-title":"Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study","volume":"66","author":"Haarhaus","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.004_bib112","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V, et\u00a0al. Diagnostic accuracy of bone turnover markers and bone histology in patients with chronic kidney disease treated by dialysis. Am J Kidney Dis, in press."},{"key":"10.1016\/j.kint.2015.12.004_bib113","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A\u00a0higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib114","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5414\/CN108407","article-title":"FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis","volume":"82","author":"Lima","year":"2014","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib115","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-3419","article-title":"Serum sclerostin and risk of hip fracture in older Caucasian women","volume":"97","author":"Arasu","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2015.12.004_bib116","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.kint.2015.12.004_bib117","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/sdi.12415","article-title":"Sclerostin, osteocytes, and chronic kidney disease - mineral bone disorder","volume":"28","author":"Moyses","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2015.12.004_bib118","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.ajkd.2009.10.049","article-title":"Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study","volume":"55","author":"Jamal","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.004_bib119","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","article-title":"Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis","volume":"26","author":"Bucur","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2015.12.004_bib120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","article-title":"Bone mineral density predicts fractures in chronic kidney disease","volume":"30","author":"West","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.12.004_bib121","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2215\/CJN.09470913","article-title":"Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis","volume":"9","author":"Malluche","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib122","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","author":"Nickolas","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.004_bib123","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.004_bib124","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2008.456","article-title":"A\u00a0rat model of chronic kidney disease-mineral bone disorder","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bone.2010.04.600","article-title":"Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure","volume":"47","author":"Nikolov","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.kint.2015.12.004_bib126","doi-asserted-by":"crossref","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","article-title":"Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease: role of sclerostin?","volume":"8","author":"Ferreira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2015.12.004_bib127","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.004_bib128","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","article-title":"The emerging role of Klotho in clinical nephrology","volume":"27","author":"Hu","year":"2012","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T04:38:45Z","timestamp":1654144725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0085253815000721"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2015.12.004","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing bone patterns with progression of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}